Pivotal Bioventure China
Company: Pivotal Bioventure China
Description: Pivotal Bioventure China, a prominent member of Nan Fung Life Sciences, operates as a venture capital fund that focuses on investing in privately held companies within the Greater China region. The firm has a strategic emphasis on identifying and supporting businesses that possess innovative therapeutic products and platforms aimed at addressing significant unmet medical needs.
Pivotal Bioventure China is committed to a robust investment strategy that revolves around the identification of promising innovative products and technologies. This approach is designed to address the growing medical needs in the Greater China region through meticulous company building and targeted investments. The organization prides itself on its dedication to assembling talented teams and facilitating the development of groundbreaking products, which enables its portfolio companies to pursue ambitious and impactful missions.
The team at Pivotal Bioventure China comprises seasoned life science investors and entrepreneurs, each with a successful track record in venture building and investment. Their collective expertise and experience uniquely position the firm to navigate the complexities of the life sciences sector, ultimately fostering advancements that can lead to improved healthcare outcomes in the region.
Industry: Venture Capital and Private Equity
Domain: http://www.pivotalbiovp.cn/
Founded: 2018
Location: Shanghai
Address: 1196 Century Avenue, Suite 1203-04, 12F, Tower 2, Century Link, Shanghai, CN
Size: 11-50 employees
Direct Contacts
Name: Dan Liu
Title: Managing Partner (管理合伙人)
Email: Direct Email
Company: Pivotal Bioventure China
LinkedIn: http://www.linkedin.com/in/liu3dan1
Industry: Venture Capital and Private Equity
Location: Shanghai, China